Warwick University has been awarded GBP2.6m to undertake Technology Assessment Reviews (TAR) of medical treatments and technologies.
The TAR team will provide the National Institute of Clinical Excellence (NICE) with essential information about clinical- and cost-effectiveness Using this information, NICE will be able to make decisions on whether to recommend technologies, including devices and diagnostics for use nationally across the NHS.
The Warwick Evidence team, led by Dr Aileen Clarke and Dr Paul Sutcliffe from Warwick Medical School, is one of three new TAR teams across the country.
Warwick Evidence brings together experts in clinical and cost-effectiveness reviewing, health economics and modelling.
The multidisciplinary team will work collaboratively across several departments at the university and will be supported by a senior team of clinical and methodological experts and advisers at both local and national level.
